Sample Applications and Summary Statements
Table of Contents
Introduction
Several investigators have graciously agreed to let us post their exceptional applications online.
We are truly indebted to the investigators listed below, who have enabled us to deliver this widely anticipated resource to the research community.
We selected these applications as sound examples of good grantsmanship, which we highlighted with annotations.
NB. The text of these applications is copyrighted. You may use it only for nonprofit educational purposes provided the document remains unchanged and the PI, the grantee organization, and NIAID are credited.
How to Print the Files
Depending on your local printer settings, you may need to adjust margins or page layout to print the full page.
R01 Sample Applications and Summary Statements
R21 Sample Applications and Summary Statements
Please note that the R21 funds novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. R21s are not intended for new investigators, and there is no evidence that they provide a path to an independent research career.
| PI and Grantee Institution |
Application Resources |
Steven W. Dow, DVM, Ph.D., of Colorado State University, Fort Collins
"Mechanisms of enteric Burkholderia psuedomallei infection" |
Summary Statement
Full Application |
Joseph M. McCune, MD, Ph.D., of the University of California, San Francisco
"Human immune system layering and the neonatal response to vaccines" |
Summary Statement
Full Application |
Peter John Myler, Ph.D., and Marilyn Parsons, Ph.D., of the Seattle Biomedical Research Institute
"Ribosome profiling of Trypanosoma brucei" |
Summary Statement
Full Application |
Howard T. Petrie, of Scripps Florida
"Lymphoid signals for stromal growth and organization in the thymus." |
Summary Statement
Full Application |
Michael N. Starnbach, Ph.D., of Harvard University Medical School
"Alteration of host protein stability by Legionella" |
Summary Statement
Full Application |
John Haynes Weis, Ph.D., of the University of Utah
"Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activation" |
Summary Statement
Full Application |
R21/R33 Sample Application and Summary Statement
The R21/R33 supports a two-phased award without a break in funding. It begins with the R21 phase for milestone-driven exploratory or feasibility studies with a possible transition to the R33 phase for expanded development. Transition to the second phase depends on several factors, including the achievement of negotiated milestones.
| PI and Grantee Institution |
Application Resources |
Stephen Dewhurst, Ph.D., of the University of Rochester
"The semen enhancer of HIV infection as a novel microbicide target" |
Summary Statement
Full Application |
Links to Other Samples and More Resources
For information about preparing the forms and page limits:
Contact Us
If you have knowledge to share or want more information on this topic, email deaweb@niaid.nih.gov with this link and your message. Thanks for helping us clarify and expand our knowledge base.